Newly formulated herbal drug may lower blood sugar in early diabetes: Study
Sri Lanka: A newly formulated herbal drug of C. grandis (500 mg per day) significantly improved blood sugar control in patients with newly diagnosed type 2 diabetes (T2D), according to a recent study in the journal Phytomedicine.
Several preclinical studies have shown the aqueous leaves extract of Coccinia grandis (Linn.) Voigt (Cucurbitaceae) to be promising for the in vivo and in vitro diabetes treatment. The present study by Keddagoda Gamage Piyumi Wasana, University of Ruhuna, Galle, Sri Lanka, and colleagues evaluated the efficacy and safety of a newly developed herbal formulation of C. grandis in newly diagnosed patients with type 2 diabetes mellitus.
For the purpose, the researchers conducted a three months long, randomized, double blind, placebo controlled clinical trial in patients with newly diagnosed T2D. The trial from the University Medical Clinic, Teaching Hospital, Karapitiya, Galle, Sri Lanka, recruited 158 newly diagnosed patients with T2DM based on fasting plasma glucose (FPG) concentration. They were randomly assigned to receive 500 mg of herbal drug (test group; n = 79) or placebo drug (placebo group; n = 79) once daily for three months.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.